SlideShare ist ein Scribd-Unternehmen logo
1 von 37
Downloaden Sie, um offline zu lesen
Objectives
Define and classify
vasculitis
Describe the cause ,
pathogenesis ,
morphology and clinical
presentation of various
types of vasculitis
Vasculitis
Vessel wall
inflammation
Pathogenesis
• Immune mediated
inflammation
• Direct invasion of vessel
wall by infectious pathology.
Non-
infectious
vasculitis
Cause – Local or systemic
immune response
Immunologic Injury is
caused by -
• Immune complex deposition
• Antineutrophil cytoplasmic
antibodies
• Antiendothelial antibody
• Autoreactive T cells
Antineutrophil Cytoplasmic
Antibodies (ANCAs)
• Heterogeneous group of autoantibodies
directed against
o neutrophil primary granules,
o monocyte lysosomes, and
o endothelial cells.
• ANCA associated vasculitis is
“pauci-immune” as vascular lesions do not
contain demonstrable antibody or
complement.
MCQ
SAQ
– Classified according to antigen specificity/
intracellular distribution of target antigen
– Anti-proteinase-3 (PR3-ANCA) / c -ANCA
• Neutrophil azurophilic granule constituent.
• trigerred by some infections
• Eg. Wegener granulomatosis/ Polyangitis
• Anti-myeloperoxidase (MPO-ANCA) / p-ANCA
– MPO is a lysosomal granule involved in generating
oxygen free radicals.
– induced by therapeutic agents- propylthiouracil
– Eg. Microscopic polyangiitis and Churg-Strauss
syndrome
ANCAs- MCQ’S ***
Antiendothelial
antibodies
Induced by
defects in immune
regulation
Eg. Kawasaki
disease
GIANT-CELL (TEMPORAL) ARTERITIS
• chronic, typically granulomatous
inflammation of large to small-
sized arteries.
• Most common form of vasculitis
• Elderly**, Rare before 50 years.
•
• Affects arteries in head
(temporal arteries-thickened,
nodular and tender) followed by
vertebral and ophthalmic
arteries.
GIANT-CELL
(TEMPORAL)
ARTERITIS..
C/F - vague and constitutional—
fever, fatigue, weight loss, facial
pain or headache
Giant-cell arteritis is a medical
emergency - prompt recognition
and treatment.
Ophthalmic arterial involvement
- permanent blindness
GIANT-CELL (TEMPORAL) ARTERITIS..
• Inflammatory lesions are segmental.
(biopsy -2- to 3-cm length of artery)
- nodular intimal thickening
- reduced luminal diameter.
• Classic lesions
- medial granulomatous inflammation that
leads to elastic lamina fragmentation.
- Multinucleated giant cells (75%)
Negative biopsy result does not exclude the
diagnosis
GIANT-CELL (TEMPORAL) ARTERITIS..
TAKAYASU ARTERITIS/ PULSELESS DISEASE
• Granulomatous vasculitis of medium and
larger arteries.
• Clinical features:
1. Ocular disturbances
2. marked weakening of pulses in upper
extremities.
• Age : less than 50 years **
TAKAYASU
ARTERITIS…
• Classically involves
• aortic arch
• – pulmonary A. , coronary and
renal arteries.
• Transmural irregular
• fibrous thickening of vessels with
intimal hyperplasia
• severe luminal
• narrowing of major branch vessels
Takayasu aortitis…
• Active disease:
destruction and
fibrosis of arterial
media associated with
mononuclear infiltrates ,
granulomatous inflammation
& giant cells
• Chronic – Collagenous
scarring with chronic
inflammatory cells.
Polyarteritis nodosa (PAN)
• Systemic vasculitis of medium or small-sized
muscular arteries.
• Typically involving renal and visceral vessels but
sparing the pulmonary circulation.
• ~ 30% of patients with PAN have chronic
hepatitis B and HBsAg is positive
– immune complex mediated etiology
• Types- Classic idiopathic PAN , Cutaneous PAN,
PAN associated with chronic hepatitis
MCQ
Polyarteritis
nodosa..
Typically Young adults.
Clinical features
- Malaise, fever, and weight loss
• Hypertension due to renal involvement
• Abdominal pain and malena
• Diffuse muscular aches and pains
• Peripheral neuritis
Therapy - corticosteroids and
cyclophosphamide
Polyarteritis nodosa..
• Morphology
• segmental transmural
necrotizing
inflammation of small to
medium-sized arteries
• affect only part of
vessel circumference.
• Vessels of kidneys,
heart, liver, and
gastrointestinal tract
Polyarteritis nodosa..
• Acute phase -
– transmural inflammation of arterial wall
– mixed infiltrate of neutrophils, eosinophils,
and mononuclear cells.
– fibrinoid necrosis
• Later phase -
- fibrous thickening of vessel wall.
• All stages of activity (early to late) coexist in
different vessels or within same vessel-
suggesting ongoing and recurrent insults.
MCQ
KAWASAKI
DISEASE/
Mucocutaneous
lymph node
syndrome
Acute febrile, self-limited illness of
infancy and childhood
arteritis affecting large to medium-
sized, and small vessels
Predilection for coronary artery
involvement - cause aneurysms -
rupture or thrombose - acute
myocardial infarctions
KAWASAKI
DISEASE…
Pathogenesis
unknown
infectious agents (viral) in triggering disease in
genetically susceptible.
Vascular damage is mediated by
activated T cells and monocytes /
macrophages
KAWASAKI DISEASE…
• Morphology –
– inflammation affecting entire thickness of
vessel wall
– fibrinoid necrosis is usually less prominent
• C/F –
– conjunctival and oral erythema and erosion
– edema of hands and feet
– erythema of palms and soles
– a desquamative rash
– cervical lymph node enlargement
(Mucocutaneous lymph node syndrome)
Microscopic polyangiitis/
hypersensitivity / leukocytoclastic vasculitis
Necrotizing vasculitis affecting capillaries,
arterioles and venules.
Necrotizing glomerulonephritis (90%) and
pulmonary capillaritis are common.
Skin, mucous membrane, lung, brain, heart, GIT,
kidney , Muscle- involvement
All lesions tend to be of same age are distributed
widely
MCQ
Microscopic polyangiitis- Pathogenesis
Antibody response to antigens – drugs
(Penicillin), micro-organisms(streptococci),
heterologous or tumour proteins.
Immune complex
deposition
recruitment & activation of
neutrophils within affected
vascular beds
Secondary immune
response – MPO ANCA
Clinical
manifestations-
Microscopic polyangiitis- Morphology
1. Segmental fibrinoid necrosis
of media
2. focal transmural necrotizing
lesions
3. granulomatous inflammation
is absent.
• Spare medium and larger
arteries- infarcts uncommon.
• In postcapillary venules only
infiltrating neutrophils, many
undergoing apoptosis-
leukocytoclastic vasculitis
• Little or no immunoglobulin
(“pauci-immune injury”).
Churg-Strauss
Syndrome /
Allergic
granulomatosis
and angitis
• Small-vessel necrotizing
vasculitis
• Associated with asthma,
allergic rhinitis, lung
infiltrates, peripheral
hypereosinophilia, and
extravascular necrotizing
granulomas.
• Mechanism : hyper
responsiveness to an
allergic stimulus in
patients with asthma
• Trigger : leukotriene
receptor antagonists
Churg-
Strauss
Syndrome…
Vascular lesions- segmental transmural
necrotizing inflammation , granulomas and
eosinophils.
MPO-ANCAs present (50%)
Multisystem diseases with -
• cutaneous involvement (palpable purpura),
• gastrointestinal tract bleeding
• renal disease (focal and segmental glomerulosclerosis)
• Myocardial involvement- cardiomyopathy
Wegener Granulomatosis/ Granulomatosis
with polyangitis
Necrotizing vasculitis characterized by –
• Necrotizing granulomas
of upper (ear, nose, sinuses, throat) or lower
respiratory tract (lung) or both
• Necrotizing or granulomatous vasculitis
small to medium-sized vessels of most
commonly lungs and upper airways
• Focal necrotizing, crescentic glomerulonephritis
MCQ
Wegener
Granulomatosis-
Pathogenesis
PR3-ANCAs (up to 95%)-
marker of disease activity,
prognosis and disease
pathogenesis.
T-cell–mediated hypersensitivity
response
Wegener Granulomatosis-
Morphology
• Upper respiratory tract lesions- Iinflammatory sinusitis
with mucosal granulomas to ulcerative lesions of nose,
palate, or pharynx, rimmed by granulomas with geographic
patterns of central necrosis and vasculitis
• Multiple granulomas coalesce to produce nodules in lung -
cavitate
• late stage - Granulomatous involvement of parenchyma and
alveolar hemorrhage
• Lesions may ultimately undergo progressive fibrosis and
organization.
Wegener’s granulomatosis…
Wegener Granulomatosis- Morphology
• Renal Lesions –
• Early : Glomeruli focal necrosism with isolated capillary
loop thrombosis (Focal and segmental necrotising
glomerulonephritis)
• Advanced: Diffuse necrosis with excuberant parietal
cell proliferation – cresent formation – (Cresentric
glomerulonephritis)
Wegener Granulomatosis- Clinical features
Males ~ 40 years
Pneumonitis with
bilateral nodular and
cavitary infiltrates
chronic sinusitis
mucosal ulcerations of
the nasopharynx
evidence of renal
disease
Behcet’s
disease
Small- to medium-vessel
neutrophilic
vasculitis
presents as a clinical triad of
recurrent oral aphthous
ulcers, genital ulcers, and
uveitis
Thromboangiitis Obliterans
(Buerger Disease)
Segmental,
thrombosing, acute and
chronic inflammation of
medium-sized and small
arteries,
tibial and radial arteries,
With secondary
extension into veins and
nerves of extremities
Leads to vascular
insufficiency of
extremities.
exclusively in heavy
cigarette smokers,
usually
before age 35
Vasculitis Associated with Other Noninfectious Disorders
Vasculitis resembling
hypersensitivity angiitis
or classic polyarteritis
nodosa
Rheumatoid arthritis-
Rheumatoid vasculitis
systemic lupus
erythematosus- Lupus
vasculitis
antiphospholipid
antibody syndrome
malignancy
Systemic illnesses-
mixed
cryoglobulinemia, and
Henoch-Schönlein
purpura.
Infectious
vasculitis
Direct invasion of
infectious agents-
Pseudomonas or fungi
Aspergillus and Mucor
species.
Mycotic aneurysms-
induce thrombosis and
infarction.

Weitere ähnliche Inhalte

Was ist angesagt?

Approach to a patient with vasculitis and its
Approach to a patient with vasculitis and itsApproach to a patient with vasculitis and its
Approach to a patient with vasculitis and its
Mohit Aggarwal
 

Was ist angesagt? (20)

Vasculitis syndrome an approach -and-basic principles of treatment
Vasculitis syndrome an approach -and-basic principles of treatmentVasculitis syndrome an approach -and-basic principles of treatment
Vasculitis syndrome an approach -and-basic principles of treatment
 
THE VASCULITIS SYNDROME
THE VASCULITIS SYNDROMETHE VASCULITIS SYNDROME
THE VASCULITIS SYNDROME
 
Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Tutorial vasculitis
Tutorial vasculitisTutorial vasculitis
Tutorial vasculitis
 
Cutaneous vasculitis
Cutaneous vasculitisCutaneous vasculitis
Cutaneous vasculitis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Approach to a patient with vasculitis and its
Approach to a patient with vasculitis and itsApproach to a patient with vasculitis and its
Approach to a patient with vasculitis and its
 
ANCA vasculitis
ANCA vasculitisANCA vasculitis
ANCA vasculitis
 
Dermatomyositis
DermatomyositisDermatomyositis
Dermatomyositis
 
Vasculitis - Wegners, churg strauss,PAN, Temporal arteritis, Buerger's disea...
Vasculitis - Wegners, churg strauss,PAN, Temporal arteritis,  Buerger's disea...Vasculitis - Wegners, churg strauss,PAN, Temporal arteritis,  Buerger's disea...
Vasculitis - Wegners, churg strauss,PAN, Temporal arteritis, Buerger's disea...
 
Blood vessel pathology
Blood vessel pathologyBlood vessel pathology
Blood vessel pathology
 
Renal amyloidosis
Renal amyloidosisRenal amyloidosis
Renal amyloidosis
 
Cryoglobulinemia ppt
Cryoglobulinemia pptCryoglobulinemia ppt
Cryoglobulinemia ppt
 
Systemic vasculitis 2016 shj
Systemic vasculitis 2016 shjSystemic vasculitis 2016 shj
Systemic vasculitis 2016 shj
 
Vasculitis undergrad: diagnosis & treatment.
Vasculitis undergrad: diagnosis & treatment.Vasculitis undergrad: diagnosis & treatment.
Vasculitis undergrad: diagnosis & treatment.
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Amyloidosis ppt
Amyloidosis pptAmyloidosis ppt
Amyloidosis ppt
 
Cvs rhd-csbrp
Cvs rhd-csbrpCvs rhd-csbrp
Cvs rhd-csbrp
 

Ähnlich wie Vasculitis pathology

Imaging of vasculitis
Imaging of vasculitis Imaging of vasculitis
Imaging of vasculitis
Ahmed Bahnassy
 
meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)
student
 

Ähnlich wie Vasculitis pathology (20)

VASCULITIS AND UPDATES
VASCULITIS  AND UPDATESVASCULITIS  AND UPDATES
VASCULITIS AND UPDATES
 
VASCULITIS AND UPDATES.pptx
VASCULITIS  AND UPDATES.pptxVASCULITIS  AND UPDATES.pptx
VASCULITIS AND UPDATES.pptx
 
APPROACH TO VASCULITIS..........pptx
APPROACH TO VASCULITIS..........pptxAPPROACH TO VASCULITIS..........pptx
APPROACH TO VASCULITIS..........pptx
 
Vaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritisVaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritis
 
Dermatology(saculitis)
Dermatology(saculitis)Dermatology(saculitis)
Dermatology(saculitis)
 
VASCULITIS.pdf
VASCULITIS.pdfVASCULITIS.pdf
VASCULITIS.pdf
 
Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...
Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...
Systemic vasculitides - Wegener's Granulomatosis, Microscopic Polyangitis, Ch...
 
Vasculitis and varicose veins
Vasculitis and varicose veinsVasculitis and varicose veins
Vasculitis and varicose veins
 
Pediatric vasculitis dr inayat ullah
Pediatric vasculitis dr inayat ullahPediatric vasculitis dr inayat ullah
Pediatric vasculitis dr inayat ullah
 
Imaging of vasculitis
Imaging of vasculitis Imaging of vasculitis
Imaging of vasculitis
 
Small vessel vasculitis
Small vessel vasculitisSmall vessel vasculitis
Small vessel vasculitis
 
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptxD. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
 
Vasculitis only
Vasculitis onlyVasculitis only
Vasculitis only
 
meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)
 
THE VASCULITIS SYNDROME
THE VASCULITIS SYNDROMETHE VASCULITIS SYNDROME
THE VASCULITIS SYNDROME
 
Pulmonary vasculitis(wegner,s granulomatosis)
Pulmonary vasculitis(wegner,s granulomatosis)Pulmonary vasculitis(wegner,s granulomatosis)
Pulmonary vasculitis(wegner,s granulomatosis)
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
04 vascular pathology
04 vascular pathology04 vascular pathology
04 vascular pathology
 
pathophysiology.pptx
pathophysiology.pptxpathophysiology.pptx
pathophysiology.pptx
 
Granulomatous diseases of nose
Granulomatous diseases of noseGranulomatous diseases of nose
Granulomatous diseases of nose
 

Mehr von SaachiGupta4

Mehr von SaachiGupta4 (20)

Aspergillus & penicillium
Aspergillus & penicilliumAspergillus & penicillium
Aspergillus & penicillium
 
Gas gangrene
Gas gangreneGas gangrene
Gas gangrene
 
Malaria
MalariaMalaria
Malaria
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugs
 
Kidney tumors
Kidney tumorsKidney tumors
Kidney tumors
 
Leprosy microbiology
Leprosy microbiologyLeprosy microbiology
Leprosy microbiology
 
Malignant bone tumors
Malignant bone tumorsMalignant bone tumors
Malignant bone tumors
 
Microbial pathogenicity
Microbial pathogenicityMicrobial pathogenicity
Microbial pathogenicity
 
Antimicrobial susceptibility testing- Microbiology
Antimicrobial susceptibility testing- MicrobiologyAntimicrobial susceptibility testing- Microbiology
Antimicrobial susceptibility testing- Microbiology
 
Glycogenolysis biochemistry- carbohydrate metabolism
Glycogenolysis  biochemistry- carbohydrate metabolismGlycogenolysis  biochemistry- carbohydrate metabolism
Glycogenolysis biochemistry- carbohydrate metabolism
 
biochemistry- Role of insulin in metabolism- PHYSIOLOGICAL ACTION OF INSULIN
biochemistry- Role of insulin in metabolism- PHYSIOLOGICAL ACTION OF INSULINbiochemistry- Role of insulin in metabolism- PHYSIOLOGICAL ACTION OF INSULIN
biochemistry- Role of insulin in metabolism- PHYSIOLOGICAL ACTION OF INSULIN
 
Biochemistry- Glucose transporters
Biochemistry- Glucose transportersBiochemistry- Glucose transporters
Biochemistry- Glucose transporters
 
Physiology- regulation of body fluids and osmolality (renal)
Physiology- regulation of body fluids and osmolality (renal)Physiology- regulation of body fluids and osmolality (renal)
Physiology- regulation of body fluids and osmolality (renal)
 
Kidney development - embryology of urinary system
Kidney development - embryology of urinary systemKidney development - embryology of urinary system
Kidney development - embryology of urinary system
 
Fallot tetralogy and Ventricular septal defect - EMBRYOLOGY
Fallot tetralogy and Ventricular septal defect - EMBRYOLOGYFallot tetralogy and Ventricular septal defect - EMBRYOLOGY
Fallot tetralogy and Ventricular septal defect - EMBRYOLOGY
 
Development of liver, pancreas, spleen and extrahepatic biliary apparatus
Development of liver, pancreas, spleen and extrahepatic biliary apparatusDevelopment of liver, pancreas, spleen and extrahepatic biliary apparatus
Development of liver, pancreas, spleen and extrahepatic biliary apparatus
 
Development of liver , extrahepatic biliary apparatus , pancreas and spleen.
Development of liver , extrahepatic biliary apparatus , pancreas and spleen.Development of liver , extrahepatic biliary apparatus , pancreas and spleen.
Development of liver , extrahepatic biliary apparatus , pancreas and spleen.
 
Fatty liver- General metabolism, biochemistry
Fatty liver- General metabolism, biochemistryFatty liver- General metabolism, biochemistry
Fatty liver- General metabolism, biochemistry
 
Urine formation renal physiology
Urine formation  renal physiologyUrine formation  renal physiology
Urine formation renal physiology
 
Micturition renal physiology
Micturition renal physiologyMicturition renal physiology
Micturition renal physiology
 

Kürzlich hochgeladen

Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 

Kürzlich hochgeladen (20)

Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 

Vasculitis pathology

  • 1. Objectives Define and classify vasculitis Describe the cause , pathogenesis , morphology and clinical presentation of various types of vasculitis
  • 2. Vasculitis Vessel wall inflammation Pathogenesis • Immune mediated inflammation • Direct invasion of vessel wall by infectious pathology.
  • 3. Non- infectious vasculitis Cause – Local or systemic immune response Immunologic Injury is caused by - • Immune complex deposition • Antineutrophil cytoplasmic antibodies • Antiendothelial antibody • Autoreactive T cells
  • 4. Antineutrophil Cytoplasmic Antibodies (ANCAs) • Heterogeneous group of autoantibodies directed against o neutrophil primary granules, o monocyte lysosomes, and o endothelial cells. • ANCA associated vasculitis is “pauci-immune” as vascular lesions do not contain demonstrable antibody or complement. MCQ SAQ
  • 5. – Classified according to antigen specificity/ intracellular distribution of target antigen – Anti-proteinase-3 (PR3-ANCA) / c -ANCA • Neutrophil azurophilic granule constituent. • trigerred by some infections • Eg. Wegener granulomatosis/ Polyangitis • Anti-myeloperoxidase (MPO-ANCA) / p-ANCA – MPO is a lysosomal granule involved in generating oxygen free radicals. – induced by therapeutic agents- propylthiouracil – Eg. Microscopic polyangiitis and Churg-Strauss syndrome ANCAs- MCQ’S ***
  • 6. Antiendothelial antibodies Induced by defects in immune regulation Eg. Kawasaki disease
  • 7.
  • 8.
  • 9. GIANT-CELL (TEMPORAL) ARTERITIS • chronic, typically granulomatous inflammation of large to small- sized arteries. • Most common form of vasculitis • Elderly**, Rare before 50 years. • • Affects arteries in head (temporal arteries-thickened, nodular and tender) followed by vertebral and ophthalmic arteries.
  • 10. GIANT-CELL (TEMPORAL) ARTERITIS.. C/F - vague and constitutional— fever, fatigue, weight loss, facial pain or headache Giant-cell arteritis is a medical emergency - prompt recognition and treatment. Ophthalmic arterial involvement - permanent blindness
  • 11. GIANT-CELL (TEMPORAL) ARTERITIS.. • Inflammatory lesions are segmental. (biopsy -2- to 3-cm length of artery) - nodular intimal thickening - reduced luminal diameter. • Classic lesions - medial granulomatous inflammation that leads to elastic lamina fragmentation. - Multinucleated giant cells (75%) Negative biopsy result does not exclude the diagnosis
  • 13. TAKAYASU ARTERITIS/ PULSELESS DISEASE • Granulomatous vasculitis of medium and larger arteries. • Clinical features: 1. Ocular disturbances 2. marked weakening of pulses in upper extremities. • Age : less than 50 years **
  • 14. TAKAYASU ARTERITIS… • Classically involves • aortic arch • – pulmonary A. , coronary and renal arteries. • Transmural irregular • fibrous thickening of vessels with intimal hyperplasia • severe luminal • narrowing of major branch vessels
  • 15. Takayasu aortitis… • Active disease: destruction and fibrosis of arterial media associated with mononuclear infiltrates , granulomatous inflammation & giant cells • Chronic – Collagenous scarring with chronic inflammatory cells.
  • 16. Polyarteritis nodosa (PAN) • Systemic vasculitis of medium or small-sized muscular arteries. • Typically involving renal and visceral vessels but sparing the pulmonary circulation. • ~ 30% of patients with PAN have chronic hepatitis B and HBsAg is positive – immune complex mediated etiology • Types- Classic idiopathic PAN , Cutaneous PAN, PAN associated with chronic hepatitis MCQ
  • 17. Polyarteritis nodosa.. Typically Young adults. Clinical features - Malaise, fever, and weight loss • Hypertension due to renal involvement • Abdominal pain and malena • Diffuse muscular aches and pains • Peripheral neuritis Therapy - corticosteroids and cyclophosphamide
  • 18. Polyarteritis nodosa.. • Morphology • segmental transmural necrotizing inflammation of small to medium-sized arteries • affect only part of vessel circumference. • Vessels of kidneys, heart, liver, and gastrointestinal tract
  • 19. Polyarteritis nodosa.. • Acute phase - – transmural inflammation of arterial wall – mixed infiltrate of neutrophils, eosinophils, and mononuclear cells. – fibrinoid necrosis • Later phase - - fibrous thickening of vessel wall. • All stages of activity (early to late) coexist in different vessels or within same vessel- suggesting ongoing and recurrent insults. MCQ
  • 20. KAWASAKI DISEASE/ Mucocutaneous lymph node syndrome Acute febrile, self-limited illness of infancy and childhood arteritis affecting large to medium- sized, and small vessels Predilection for coronary artery involvement - cause aneurysms - rupture or thrombose - acute myocardial infarctions
  • 21. KAWASAKI DISEASE… Pathogenesis unknown infectious agents (viral) in triggering disease in genetically susceptible. Vascular damage is mediated by activated T cells and monocytes / macrophages
  • 22. KAWASAKI DISEASE… • Morphology – – inflammation affecting entire thickness of vessel wall – fibrinoid necrosis is usually less prominent • C/F – – conjunctival and oral erythema and erosion – edema of hands and feet – erythema of palms and soles – a desquamative rash – cervical lymph node enlargement (Mucocutaneous lymph node syndrome)
  • 23. Microscopic polyangiitis/ hypersensitivity / leukocytoclastic vasculitis Necrotizing vasculitis affecting capillaries, arterioles and venules. Necrotizing glomerulonephritis (90%) and pulmonary capillaritis are common. Skin, mucous membrane, lung, brain, heart, GIT, kidney , Muscle- involvement All lesions tend to be of same age are distributed widely MCQ
  • 24. Microscopic polyangiitis- Pathogenesis Antibody response to antigens – drugs (Penicillin), micro-organisms(streptococci), heterologous or tumour proteins. Immune complex deposition recruitment & activation of neutrophils within affected vascular beds Secondary immune response – MPO ANCA Clinical manifestations-
  • 25. Microscopic polyangiitis- Morphology 1. Segmental fibrinoid necrosis of media 2. focal transmural necrotizing lesions 3. granulomatous inflammation is absent. • Spare medium and larger arteries- infarcts uncommon. • In postcapillary venules only infiltrating neutrophils, many undergoing apoptosis- leukocytoclastic vasculitis • Little or no immunoglobulin (“pauci-immune injury”).
  • 26. Churg-Strauss Syndrome / Allergic granulomatosis and angitis • Small-vessel necrotizing vasculitis • Associated with asthma, allergic rhinitis, lung infiltrates, peripheral hypereosinophilia, and extravascular necrotizing granulomas. • Mechanism : hyper responsiveness to an allergic stimulus in patients with asthma • Trigger : leukotriene receptor antagonists
  • 27. Churg- Strauss Syndrome… Vascular lesions- segmental transmural necrotizing inflammation , granulomas and eosinophils. MPO-ANCAs present (50%) Multisystem diseases with - • cutaneous involvement (palpable purpura), • gastrointestinal tract bleeding • renal disease (focal and segmental glomerulosclerosis) • Myocardial involvement- cardiomyopathy
  • 28. Wegener Granulomatosis/ Granulomatosis with polyangitis Necrotizing vasculitis characterized by – • Necrotizing granulomas of upper (ear, nose, sinuses, throat) or lower respiratory tract (lung) or both • Necrotizing or granulomatous vasculitis small to medium-sized vessels of most commonly lungs and upper airways • Focal necrotizing, crescentic glomerulonephritis MCQ
  • 29. Wegener Granulomatosis- Pathogenesis PR3-ANCAs (up to 95%)- marker of disease activity, prognosis and disease pathogenesis. T-cell–mediated hypersensitivity response
  • 30. Wegener Granulomatosis- Morphology • Upper respiratory tract lesions- Iinflammatory sinusitis with mucosal granulomas to ulcerative lesions of nose, palate, or pharynx, rimmed by granulomas with geographic patterns of central necrosis and vasculitis • Multiple granulomas coalesce to produce nodules in lung - cavitate • late stage - Granulomatous involvement of parenchyma and alveolar hemorrhage • Lesions may ultimately undergo progressive fibrosis and organization.
  • 32. Wegener Granulomatosis- Morphology • Renal Lesions – • Early : Glomeruli focal necrosism with isolated capillary loop thrombosis (Focal and segmental necrotising glomerulonephritis) • Advanced: Diffuse necrosis with excuberant parietal cell proliferation – cresent formation – (Cresentric glomerulonephritis)
  • 33. Wegener Granulomatosis- Clinical features Males ~ 40 years Pneumonitis with bilateral nodular and cavitary infiltrates chronic sinusitis mucosal ulcerations of the nasopharynx evidence of renal disease
  • 34. Behcet’s disease Small- to medium-vessel neutrophilic vasculitis presents as a clinical triad of recurrent oral aphthous ulcers, genital ulcers, and uveitis
  • 35. Thromboangiitis Obliterans (Buerger Disease) Segmental, thrombosing, acute and chronic inflammation of medium-sized and small arteries, tibial and radial arteries, With secondary extension into veins and nerves of extremities Leads to vascular insufficiency of extremities. exclusively in heavy cigarette smokers, usually before age 35
  • 36. Vasculitis Associated with Other Noninfectious Disorders Vasculitis resembling hypersensitivity angiitis or classic polyarteritis nodosa Rheumatoid arthritis- Rheumatoid vasculitis systemic lupus erythematosus- Lupus vasculitis antiphospholipid antibody syndrome malignancy Systemic illnesses- mixed cryoglobulinemia, and Henoch-Schönlein purpura.
  • 37. Infectious vasculitis Direct invasion of infectious agents- Pseudomonas or fungi Aspergillus and Mucor species. Mycotic aneurysms- induce thrombosis and infarction.